Cliff Asness’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.3M Buy
367,365
+40,048
+12% +$3.51M 0.01% 994
2026
Q1
$29M Buy
327,317
+3,597
+1% +$330K 0.01% 887
2025
Q4
$29.1M Sell
323,720
-606,179
-65% -$57.5M 0.02% 823
2025
Q3
$91.6M Sell
929,899
-370,694
-29% -$36.7M 0.06% 436
2025
Q2
$119M Buy
1,300,593
+955,284
+277% +$92.4M 0.1% 290
2025
Q1
$38.8M Sell
345,309
-77,371
-18% -$8.28M 0.04% 533
2024
Q4
$44.6M Buy
422,680
+878
+0.2% +$94.2K 0.06% 419
2024
Q3
$45.4M Buy
421,802
+1,023
+0.2% +$112K 0.06% 398
2024
Q2
$45.4M Buy
420,779
+7,358
+2% +$867K 0.07% 356
2024
Q1
$54.6M Sell
413,421
-34,500
-8% -$4.31M 0.09% 263
2023
Q4
$54.5M Buy
447,921
+34,147
+8% +$3.81M 0.1% 248
2023
Q3
$46.4M Buy
413,774
+194,715
+89% +$24.7M 0.1% 257
2023
Q2
$31.9M Buy
219,059
+46,787
+27% +$6.36M 0.07% 332
2023
Q1
$22.1M Buy
172,272
+19,428
+13% +$2.44M 0.05% 438
2022
Q4
$19.4M Buy
152,844
+15,626
+11% +$1.81M 0.04% 488
2022
Q3
$14.3M Buy
137,218
+22,455
+20% +$2.46M 0.04% 546
2022
Q2
$11.9M Sell
114,763
-11,692
-9% -$1.39M 0.03% 627
2022
Q1
$16.2M Sell
126,455
-6,984
-5% -$842K 0.03% 606
2021
Q4
$16.5M Buy
133,439
+19,845
+17% +$2.6M 0.03% 547
2021
Q3
$16.1M Buy
113,594
+19,230
+20% +$2.83M 0.03% 532
2021
Q2
$14.7M Buy
94,364
+21,647
+30% +$3.51M 0.03% 586
2021
Q1
$11.3M Buy
72,717
+24,301
+50% +$3.76M 0.02% 653
2020
Q4
$7.24M Sell
48,416
-73,680
-60% -$10.4M 0.01% 690
2020
Q3
$16.1M Sell
122,096
-138,809
-53% -$18.1M 0.03% 526
2020
Q2
$29.5M Buy
260,905
+13,249
+5% +$1.53M 0.05% 394
2020
Q1
$23.8M Buy
247,656
+99,003
+67% +$13M 0.04% 450
2019
Q4
$21.6M Buy
148,653
+45,772
+44% +$6.32M 0.02% 570
2019
Q3
$13.7M Sell
102,881
-89,736
-47% -$11.6M 0.02% 670
2019
Q2
$21.5M Buy
192,617
+18,066
+10% +$2.12M 0.02% 574
2019
Q1
$21.5M Buy
174,551
+113,098
+184% +$12.9M 0.02% 589
2018
Q4
$6.19M Buy
61,453
+50,058
+439% +$5.63M 0.01% 890
2018
Q3
$1.45M Sell
11,395
-3,217
-22% -$383K ﹤0.01% 1536
2018
Q2
$1.58M Sell
14,612
-98,974
-87% -$10.8M ﹤0.01% 1533
2018
Q1
$12M Sell
113,586
-68,191
-38% -$7.92M 0.01% 719
2017
Q4
$21.3M Buy
181,777
+32,820
+22% +$3.71M 0.02% 592
2017
Q3
$16.9M Sell
148,957
-53,211
-26% -$6.14M 0.02% 627
2017
Q2
$25.2M Buy
202,168
+184,685
+1,056% +$21.9M 0.03% 547
2017
Q1
$2.07M Sell
17,483
-6,860
-28% -$778K ﹤0.01% 1365
2016
Q4
$2.44M Sell
24,343
-82,172
-77% -$8.81M ﹤0.01% 1314
2016
Q3
$13.4M Buy
106,515
+9,407
+10% +$1.16M 0.02% 673
2016
Q2
$11.3M Sell
97,108
-11,347
-10% -$1.28M 0.02% 692
2016
Q1
$11.2M Sell
108,455
-24,014
-18% -$2.32M 0.02% 657
2015
Q4
$13.2M Sell
132,469
-2,472
-2% -$242K 0.02% 658
2015
Q3
$12.3M Sell
134,941
-215,974
-62% -$21.7M 0.02% 578
2015
Q2
$37.2M Sell
350,915
-150,333
-30% -$16.6M 0.07% 320
2015
Q1
$57.2M Sell
501,248
-128,399
-20% -$14.6M 0.13% 201
2014
Q4
$69.3M Sell
629,647
-99,979
-14% -$10.5M 0.15% 195
2014
Q3
$71.2M Buy
729,626
+47,366
+7% +$4.66M 0.2% 138
2014
Q2
$68.8M Buy
682,260
+122,982
+22% +$12M 0.19% 147
2014
Q1
$51.4M Buy
559,278
+133,488
+31% +$12.3M 0.16% 168
2013
Q4
$38.5M Sell
425,790
-32,738
-7% -$2.83M 0.12% 232
2013
Q3
$36.6M Sell
458,528
-200,846
-30% -$15.8M 0.13% 208
2013
Q2
$48M Buy
+659,374
New +$49.3M 0.17% 146

Other funds holding ZBH

Cliff Asness's ZBH Position: Q2 2026 in Review

Cliff Asness increased its Zimmer Biomet (ZBH) stake by 12% in Q2 2026, buying an estimated $3.51M and bringing the position to 367,365 shares worth $31.3M. The position accounts for 0.01% of the portfolio, ranked #994.

Cliff Asness first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $119M in Q2 2025. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Cliff Asness held 367,365 shares of Zimmer Biomet worth $31.3M as of Q2 2026.
  • Cliff Asness bought 40,048 Zimmer Biomet shares in Q2 2026, an estimated $3.51M.
  • Zimmer Biomet made up 0.01% of Cliff Asness's portfolio in Q2 2026, its #994 holding.
  • Cliff Asness first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Cliff Asness's Zimmer Biomet position peaked at $119M in Q2 2025.
  • 904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.